Similar Items: Effect of intravenous vitamin C administration on chemotherapy-induced adverse events in patients with nasopharyngeal cancer
- Adverse events in different administration routes of Edaravone: A pharmacovigilance study based on the FDA adverse event reporting system
- Correction: Adherence to intravenous chemotherapy and associated factors among patients with cancer at Hawassa University Comprehensive Specialized Hospital Cancer Treatment Center, Sidama Region, Southern Ethiopia
- Disproportionality analysis of fondaparinux associated adverse events based on the FDA adverse event reporting system
- Exploring adverse events associated with vosoritide monotherapy: Insights from the FDA Adverse Event Reporting System
- Alterations in the CTRB2 gene and response to chemotherapy in pancreatic cancer
- Soluble ST2 as a biomarker for predicting severe adverse events among pediatric patients with Mycoplasma pneumoniae pneumonia